These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 200493)

  • 1. Pancreatic action of the sulfonylureas.
    Grodsky GM; Epstein GH; Fanska R; Karam JH
    Fed Proc; 1977 Dec; 36(13):2714-9. PubMed ID: 200493
    [No Abstract]   [Full Text] [Related]  

  • 2. Interacting effects of sulfonylureas and glucose on cyclic AMP metabolism and insulin release in pancreatic islets of the rat.
    Grill V; Cerasi E
    J Clin Invest; 1978 May; 61(5):1346-54. PubMed ID: 207736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the action of tolbutamide in normal man. 3. Interaction of tolbutamide with glucagon, aminophylline and arginine in stimulating insulin response.
    Widström A; Cerasi E
    Acta Endocrinol (Copenh); 1973 Mar; 72(3):532-44. PubMed ID: 4346919
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyaluronidase-induced inhibition of the insulinotropic action of sulfonylureas, leucine, and glucagon in rodent isolated pancreatic islets.
    Macchi IA; Zeytinoğlu FN
    Horm Metab Res; 1976 Mar; 8(2):92-6. PubMed ID: 177348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function.
    Gregorio F; Ambrosi F; Cristallini S; Pedetti M; Filipponi P; Santeusanio F
    Diabetes Res Clin Pract; 1992 Dec; 18(3):197-206. PubMed ID: 1289021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].
    Poltorak VV; Gladkikh AI
    Probl Endokrinol (Mosk); 1985; 31(2):76-85. PubMed ID: 2859589
    [No Abstract]   [Full Text] [Related]  

  • 7. Secretion of glucagon and insulin in hypophysectomized rats: effect of tolbutamide.
    Dunbar JC; Walsh MF; Foà PP
    Horm Res; 1979; 11(2):81-91. PubMed ID: 383597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and morphological events associated with the development of fetal rat pancreas "in vivo" and "in vitro": effect of glucagon and of other agents.
    Lambert AE; Orci L; Kanazawa Y; Jeanrenaud B; Renold AE
    Acta Isot (Padova); 1970; 10(3):191-204. PubMed ID: 4334397
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on new sulfonylurea derivatives and their metabolites in isolated Langerhans's islets of the rat pancreas (author's transl].
    Krause U; Puchinger H; Wacker A
    Arzneimittelforschung; 1975 Aug; 25(8):1231-3. PubMed ID: 810148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of sulfonylurea stimulation of insulin release.
    Hellman B
    Acta Biol Med Ger; 1982; 41(12):1211-9. PubMed ID: 6765162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (Pro-) insulin biosynthesis and release of newly synthesized (pro-) insulin from isolated islets of rat pancreas in the presence of amino acids and sulphonylureas.
    Schatz H; Nierle C; Pfeiffer EF
    Eur J Clin Invest; 1975 Nov; 5(6):477-85. PubMed ID: 811472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of a new sulfonylurea on insulin and glucagon secretion in the isolated perfused pancreas].
    Laube H; Fussgänger RD; Schröder KE; Pfeiffer EF
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2186. PubMed ID: 4579624
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 14. Early insulin and glucagon response to subsequent pulses of arginine, glucose, and tolbutamide in normal man.
    Greco AV; Manna R; Ghirlanda G; Altomonte L; Rebuzzi AG; Bertoli A
    Am J Physiol; 1979 Feb; 236(2):E85-9. PubMed ID: 369391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas.
    Gotfredsen CF
    Diabetologia; 1976 Aug; 12(4):339-42. PubMed ID: 134920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of acid amyloglucosidase in sulphonylurea-induced insulin release.
    Lundquist I
    Diabetologia; 1974 Dec; 10(6):717-24. PubMed ID: 4374400
    [No Abstract]   [Full Text] [Related]  

  • 17. The stimulus-secretion coupling of glucose-induced insulin release-XVII. Effects of sulfonylureas and diazoxide on insular biosynthetic activity.
    Levy J; Malaisse WJ
    Biochem Pharmacol; 1975 Jan; 24(2):235-9. PubMed ID: 1089409
    [No Abstract]   [Full Text] [Related]  

  • 18. Biosynthesis of proinsulin and insulin in newborn rat pancreas. Interaction of glucose, cyclic AMP, somatostatin, and sulfonylureas on the (3H) leucine incorporation into immunoreactive insulin.
    Garcia SD; Jarrousse C; Rosselin G
    J Clin Invest; 1976 Jan; 57(1):230-43. PubMed ID: 173741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and secretion of insulin in dynamic perfusion systems.
    Grodsky GM; Sando H; Levin S; Gerich J; Karam J
    Adv Metab Disord; 1974; 7(0):155-70. PubMed ID: 4607146
    [No Abstract]   [Full Text] [Related]  

  • 20. The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs.
    Zhang CL; Katoh M; Shibasaki T; Minami K; Sunaga Y; Takahashi H; Yokoi N; Iwasaki M; Miki T; Seino S
    Science; 2009 Jul; 325(5940):607-10. PubMed ID: 19644119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.